Monte Rosa Therapeutics, Inc

Contract - Research Associate - High Throughput Cellular Assays (6 Months)

Job Locations CH-Basel
ID
2025-1130
Category
Biomolecular Sciences
Position Type
Contract

Overview

Monte Rosa Therapeutics is seeking a passionate Research Associate with the experience to implement and run complex cellular assays for a 6 Month Contract. This position is a key role in the pivotal team responsible for Automation and Screening Technologies & hits-to-leads support for Monte Rosa’s diverse pipeline. The ideal candidate will be able to help evolve Monte Rosa’s hit identification and hits-to-leads endeavors through embracing novel assay technologies, enhancing overall process and actively drive internal and external partnerships.

Responsibilities

  • Perform a variety of molecular and cellular biology techniques, including mammalian cell culture, DNA/RNA isolation, and Western blotting
  • Implement and help to execute cell-based assays using various technologies (e.g., fluorescence, luminescence, TR-FRET, AlphaScreen)
  • Utilize automated liquid handling systems and laboratory robotics
  • Analyze and interpret experimental data, compile results, and present findings to the team
  • Maintain cell lines and prepare stock solutions
  • Manage laboratory inventories and handle biohazardous materials according to safety protocols
  • Ensure compliance with laboratory safety procedures and guidelines

Qualifications

  • Bachelor degree or equivalent in Biochemistry, Cell Biology or a life science with 1-2 years of industrial experience.
  • Experience with mammalian cell culture and cell line generation. CRISPR experience is a plus.
  • Proven track record for striving for high level of innovation and scientific excellence.
  • Flexibility to accommodate to rapidly changing priorities and deadlines.
  • Ability to work in a team-based environment.
  • Excellent oral and written communication skills.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed